ORIF vs DFR for Distal Femur Fracture
Trial Summary
What is the purpose of this trial?
Supracondylar femur periprosthetic fractures about a total knee arthroplasty (TKA) are a catastrophic and challenging complication of TKA and unfortunately are increasing in incidence. Fixation of these fractures can be challenging due to altered anatomy for the TKA and the presence of the metallic femoral component and have a relatively high complication rate. As a result, some surgeons elect to treat these fractures with a distal femur replacement total knee arthroplasty (DFR). The purpose of this study is to prospectively evaluate periprosthetic femur fractures treated with ORIF or DFR and compare various outcomes measures (Get up and go times, KOOS Jr score)
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Distal Femur Replacement Total Knee Arthroplasty for Distal Femur Fracture?
Research comparing Distal Femoral Replacement (DFR) and Open Reduction and Internal Fixation (ORIF) for distal femur fractures suggests that both treatments are used for managing these fractures, with studies focusing on comparing complication rates, implant survivorship, and clinical outcomes. Although direct comparisons are limited, pooled data from systematic reviews indicate that both methods have been effective in managing periprosthetic distal femur fractures.12345
Is it safe to undergo ORIF or DFR for distal femur fractures?
Research comparing ORIF (open reduction and internal fixation) and DFR (distal femoral replacement) for distal femur fractures shows that both procedures have been studied for their safety, with complication rates being a key focus. While specific safety data for each procedure varies, both have been used in treating similar conditions, indicating a level of safety in humans.12345
How does the treatment of distal femur fractures with DFR and ORIF differ from other treatments?
Distal Femur Replacement (DFR) and Open Reduction and Internal Fixation (ORIF) are unique surgical options for treating severe fractures of the lower thigh bone near the knee. DFR involves replacing the damaged bone with a metal implant, which can allow for quicker recovery and mobility, especially in older patients, while ORIF uses metal plates and screws to hold the bone together, which may be more suitable for younger patients with better bone quality.12456
Eligibility Criteria
This trial is for English-speaking patients aged 55 or older with specific types of periprosthetic femur fractures (Su Type II or III) who need surgery and are medically fit for it. It excludes those with open fractures, multiple major injuries, knee prosthetic infections, inability to have surgery, or cancer-related fractures.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either open reduction internal fixation (ORIF) or distal femur replacement (DFR) for distal femur fractures
Follow-up
Participants are monitored for safety and effectiveness after treatment, including Timed Up and Go Test and KOOS Jr assessment
Treatment Details
Interventions
- Distal Femur Replacement Total Knee Arthroplasty
- Open Reduction and Internal Fixation
Distal Femur Replacement Total Knee Arthroplasty is already approved in United States, European Union, Canada for the following indications:
- Severe osteoarthritis
- Rheumatoid arthritis
- Traumatic arthritis
- Bone tumors
- Periprosthetic fractures
- Severe osteoarthritis
- Rheumatoid arthritis
- Traumatic arthritis
- Bone tumors
- Periprosthetic fractures
- Severe osteoarthritis
- Rheumatoid arthritis
- Traumatic arthritis
- Bone tumors
- Periprosthetic fractures
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor